
Date: May 7, 2020 Source 1: University of Cambridge Source 2: www.sciencedaily.com Summary: Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an Read More …